会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明公开
    • FISH-ORIGIN CHONDROITIN SULFATE/DERMATAN SULFATE HYBRID CHAIN
    • EN EN EN EN EN EN EN EN EN EN EN EN EN EN EN EN EN
    • EP1746108A1
    • 2007-01-24
    • EP05736922.5
    • 2005-04-25
    • MARUHA CORPORATIONSugahara, Kazuyuki
    • SUGAHARA, Kazuyuki
    • C08B37/08A61K31/737A61P7/02A61P25/00A61P25/28A61K35/60
    • C08B37/0069A61K31/715
    • It is intended to provide a novel chondroitin sulfate/dermatan sulfate hybrid chain having biding activity toward a variety of growth factors, neurite outgrowth-promoting activity, and anticoagulant activity and to provide a composition for neurological disease treatment. The novel chondroitin sulfate/dermatan sulfate hybrid chain was separated and purified from the bodies of fishes other than bony fishes. When shark skin is used, the hybrid chain comprises a disaccharide GlcUA(2S)-GalNAc(4S) and has an average molecular weight of 65 to 75 kDa, and the degree of sulfation per disaccharide molecule falls within the range of 0.7 or more to less than 1.20. The hybrid chain is capable of binding to a variety of growth factors and further possesses neurite outgrowth-promoting activity and anticoagulant activity.
    • 本发明提供一种硫酸软骨素/硫酸皮肤素复合链,其具有针对各种生长因子,神经突促生长活性和抗凝血活性的粘合活性,并提供用于神经系统疾病治疗的组合物。 将硫酸软骨素/硫酸皮肤素杂交链从骨鱼以外的鱼体中分离纯化。 当使用鲨鱼皮时,杂交链包含二糖GlcUA(2S)-GalNAc(4S),平均分子量为65至75kDa,每个二糖分子的硫酸化程度在0.7以上至 小于1.20。 杂交链能够与多种生长因子结合,进一步具有神经突促生长活性和抗凝血活性。